Strategic Wealth Investment Group, LLC Coh Bar, Inc. Transaction History

Strategic Wealth Investment Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.17 - $0.34 $7,741 - $15,482	-45,537 Reduced 42.69%	61,120 $12,000
Q1 2022 Apr 26, 2022	SELL	$0.25 - $0.43 $3,019 - $5,193	-12,078 Reduced 10.17%	106,657 $34,000
Q4 2021 Jan 21, 2022	BUY	$0.34 - $1.0 $12,871 - $37,858	37,858 Added 46.81%	118,735 $42,000
Q3 2021 Nov 15, 2021	BUY	$0.96 - $1.62 $30,956 - $52,238	32,246 Added 66.31%	80,877 $79,000
Q2 2021 Jul 16, 2021	BUY	$1.09 - $1.49 $9,218 - $12,600	8,457 Added 21.05%	48,631 $68,000
Q1 2021 Apr 22, 2021	BUY	$1.26 - $2.02 $517 - $830	411 Added 1.03%	40,174 $55,000
Q4 2020 Jan 26, 2021	BUY	$0.9 - $1.54 $35,786 - $61,235	39,763 New	39,763 $53,000
Q4 2020 Jan 15, 2021	SELL	$0.9 - $1.54 $25,907 - $44,330	-28,786 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$0.87 - $2.08 $6,376 - $15,244	7,329 Added 34.16%	28,786 $27,000
Q2 2020 Jul 13, 2020	BUY	$1.08 - $4.0 $23,173 - $85,828	21,457 New	21,457 $33,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Strategic Wealth Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Wealth Investment Group, LLC with notifications on news.